Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Gmp Medicare Sdn. Bhd.

Approvalsdevice cleared8 Sept 2026

Gmp Medicare Sdn. Bhd.

8 Sept 2026: Device cleared · Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim; Nitrile Powder Free Examination Glove, Violet Blue Tested for Use with 32 Chemotherapy Drugs, Xylazine, Fentanyl & Gastric Acid. Recorded in the openFDA device 510(k) data.

View the source record

Decided
8 Sept 2026
Device
Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim; Nitrile Powder Free Examination Glove, Violet Blue Tested for Use with 32 Chemotherapy Drugs, Xylazine, Fentanyl & Gastric Acid
Specialty
General Hospital
Country
Malaysia
Location
Klang
Clearance type
Special
510(k) number
K260312
Submitted
2026-01-30
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Gmp Medicare Sdn. Bhd.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in General Hospital

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.